The all-in-one platform to find and track your stocks and investments
Discover the features
Statistics
Market Cap
3 billion
PE Ratio
-
Beta (volatility)
0.64
Earnings Per Share
-1.16
About
ISIN : US92686J1060
Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective...
Price
Performance Comparison
| Viking Therapeutics Inc | |
|---|---|
| 1 year return |
-52 %
|
| 5 years return |
+235 %
|
Valuation
| Price to Book | Payout ratio | PEG Ratio |
|---|---|---|
| 3.49 | 0 % | -0.03 |
| Price to Sales | Price / FCF | E.V.R. |
|---|---|---|
| -30.69 | 0.00 |
Price–Earnings Ratio History
The Price–Earnings Ratio history is not available for this stock.
Dividend History
It looks like no dividends is being distributed for this stock...
Number of Outstanding Shares
Financials
Year-over-Year growth
Profitability
Health
News
Earnings report announcement
7/22/2025
Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.
6/18/2025
Was Jim Cramer Right to Favor Another Stock Over Viking Therapeutics (VKTX)?
6/9/2025
Could Viking Therapeutics Become the Next Eli Lilly?
6/2/2025
Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock Has More Upside?
5/27/2025
Better Weight Loss Stock: Amgen or Viking Therapeutics?
5/22/2025
Why Viking Therapeutics Stock Bumped 3% Higher Today
5/16/2025
Novo Nordisk Sheds 4% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price
5/16/2025
LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study
4/21/2025
Eli Lilly Rockets 14% After Solidifying Its Lead For A Weight-Loss Pill
4/17/2025
Create a portfolio & add this stock
Add this stock and others to your own virtual portfolio and get personalised information : total annual dividends & total value, sectors breakdown, etc.
Privacy Policy • Terms and Conditions
© Copyright 2020-2025 Epsylia OÜ - All rights reserved
Moning is a platform that does not manage any funds and is purely educational. We do not provide any investment advice.
The data presented comes from different providers and may contain errors. We encourage you to always verify information through other sources.
Any financial investment involves risks including partial or total loss of capital.
The data presented comes from different providers and may contain errors. We encourage you to always verify information through other sources.
Any financial investment involves risks including partial or total loss of capital.